FULVESTRANT
| Brand name | FULVESTRANT |
|---|---|
| Active ingredient | FULVESTRANT |
| Strength | 250MG/5ML (50MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR |
| Modality | Small molecule |
| FDA approval | May 2019 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9271990 | May 2034 | product |
| 9833459 | February 2034 | product |
| 10188663 | February 2034 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.